Enumeral Biomedical Holdings, Inc.
company.status.inactiveCIK 1561551fmd_1GYE1NY57K6E4KATRS9M8CSPD4Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: May 01, 2012 to Sep 30, 2017, 24 periods
Latest annual · FY2015
Millions- Total revenues
- 1
- Operating income
- (7)
- Net income
- (12)
- Free cash flow
- (10)
Latest quarter · Q3 FY2017
Millions- Operating income
- (1)
- Net income
- (1)
- Free cash flow
- (1)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2013 to FY2015
- n/m
Enumeral Biomedical Holdings, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2016 | FY2015 | Change | Source |
|---|---|---|---|---|
| Operating income | -$7 million | -$10.7 million | 10-K 2017-03-28 · proof | |
| Net income | -$11.9 million | $3.3 million | -460.4% | 10-K 2017-03-28 · proof |
| Cash from operating activities | -$5.7 million | -$9.3 million | 10-K 2017-03-28 · proof | |
| Total assets | $4.9 million | $6.3 million | -22% | 10-K 2017-03-28 · proof |
| Total liabilities | $1 million | $3.9 million | -73.1% | 10-K 2017-03-28 · proof |
| Cash and cash equivalents | $3.2 million | $3.6 million | -12.1% | 10-K 2017-03-28 · proof |
- What was Enumeral Biomedical Holdings, Inc.'s operating income in fiscal 2016?
- Enumeral Biomedical Holdings, Inc. reported operating income of -$7 million for fiscal 2016 (the year ended Dec 31, 2016), against -$10.7 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2017. SEC
- What was Enumeral Biomedical Holdings, Inc.'s net income in fiscal 2016?
- Enumeral Biomedical Holdings, Inc. reported net income of -$11.9 million for fiscal 2016 (the year ended Dec 31, 2016), against $3.3 million the year before (-460.4%). Source: the 10-K filed with the SEC on Mar 28, 2017. SEC
- What was Enumeral Biomedical Holdings, Inc.'s cash from operating activities in fiscal 2016?
- Enumeral Biomedical Holdings, Inc. reported cash from operating activities of -$5.7 million for fiscal 2016 (the year ended Dec 31, 2016), against -$9.3 million the year before. Source: the 10-K filed with the SEC on Mar 28, 2017. SEC
- What are Enumeral Biomedical Holdings, Inc.'s total assets?
- As of Dec 31, 2016, Enumeral Biomedical Holdings, Inc. reported total assets of $4.9 million, against $6.3 million a year earlier (-22%). Source: the 10-K filed with the SEC on Mar 28, 2017. SEC
- What are Enumeral Biomedical Holdings, Inc.'s total liabilities?
- As of Dec 31, 2016, Enumeral Biomedical Holdings, Inc. reported total liabilities of $1 million, against $3.9 million a year earlier (-73.1%). Source: the 10-K filed with the SEC on Mar 28, 2017. SEC
- What are Enumeral Biomedical Holdings, Inc.'s cash and cash equivalents?
- As of Dec 31, 2016, Enumeral Biomedical Holdings, Inc. reported cash and cash equivalents of $3.2 million, against $3.6 million a year earlier (-12.1%). Source: the 10-K filed with the SEC on Mar 28, 2017. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1561551&period_type=annual&limit=5"Information only, not investment advice.